87 results
Page 4 of 5
10-K
urvcm6dug5j rfvz
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
nkz4xhye4p wtgzm1b
31 Mar 21
Annual report
4:30pm
10-K
EX-10.3
rnt hedqv76ahoed6
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
79fan6bl
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
asu 4i00f
29 Jan 21
Shelf registration
4:48pm
S-3
EX-5.1
bv2yfx6tdkoasfy
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
t0qbzybxq6o
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
a60ai1a1
29 Jan 21
Shelf registration
4:48pm
S-8
EX-5.1
qws 0yzkjk0tox6e3eh
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-99.1
y1bj3jqm
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.1
frp2dff25 jskqh0bo5n
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-99.1
ivbgqxpfrif
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
4aitfp i8rn
2 Nov 20
Prospectus supplement
12:00am